Translational Development Acquisition Corp. - Current Ratio

The Current Ratio as of June 2026 (TTM) for Translational Development Acquisition Corp. (TDACU) is 0.09

According to Translational Development Acquisition Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 0.09. This represents a change of -61.08% compared to the average of 0.22 of the last 4 quarters.

Translational Development Acquisition Corp. (TDACU) Historical Current Ratio (quarterly & annually)

How has TDACU Current Ratio performed in the past?

The mean historical Current Ratio of Translational Development Acquisition Corp. over the last ten years is 0.82. The current 0.09 Current Ratio has changed 964.58% with respect to the historical average. Over the past ten years (40 quarters), TDACU's Current Ratio was at its highest in in the December 2024 quarter at 3.09. The Current Ratio was at its lowest in in the March 2023 quarter at 0.

Translational Development Acquisition Corp. (TDACU) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Translational Development Acquisition Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Translational Development Acquisition Corp. (TDACU) Average Current Ratio

How has TDACU Current Ratio performed in the past?

The current Current Ratio of Translational Development Acquisition Corp. (TDACU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Translational Development Acquisition Corp. (TDACU) Current Ratio vs. Peers

How is TDACU’s Current Ratio compared to its peers?

Translational Development Acquisition Corp.’s Current Ratio is greater than dMY Squared Technology Group, Inc. (0.01), greater than WinVest Acquisition Corp. (0.02), greater than Black Hawk Acquisition Corporation (0.08), less than FutureTech II Acquisition Corp. (0.21), less than Willow Lane Acquisition Corp. (0.17), greater than Horizon Space Acquisition I Corp. Ordinary Shares (0.01), less than Four Leaf Acquisition Corporation (0.80), less than Welsbach Technology Metals Acquisition Corp. (0.12), less than Renatus Tactical Acquisition Corp I Class A Ordinary Shares (3.20), less than ESH Acquisition Corp. (0.11),

Build a custom stock screener for Translational Development Acquisition Corp. (TDACU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Translational Development Acquisition Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Translational Development Acquisition Corp. (TDACU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Translational Development Acquisition Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.